Tumor Therapy: Targeted Substances Metabolism Reprogramming Induces Tumor Ferroptosis

被引:0
|
作者
Zhang, Jin-Ping [1 ,2 ]
Wang, Yue-Qing [1 ,2 ,3 ]
Wang, Mo [3 ,4 ]
Wang, Xin-Yue [1 ,2 ]
Mou, Xiao-Qin [1 ,2 ]
Zheng, Xi [1 ,2 ]
Cheng, Chuang [1 ,2 ]
He, Jing [1 ,2 ]
Zou, Li-Li [1 ,2 ,3 ]
Liu, Xiao-Wen [1 ,2 ,3 ]
机构
[1] China Three Gorges Univ, Hubei Key Lab Tumor Microenvironm & Immunotherapy, Yichang 443002, Peoples R China
[2] China Three Gorges Univ, Coll Basic Med Sci, Yichang 443002, Peoples R China
[3] China Three Gorges Univ, Hubei Prov Clin Res Ctr Precise Prevent & Treatmen, Peoples Hosp 2, Yichang 443002, Peoples R China
[4] China Three Gorges Univ, Peoples Hosp Yichang 2, Dept Anesthesia, Peoples Hosp 2, Yichang 443002, Peoples R China
关键词
tumor therapy; ferroptosis; substance metabolism reprogramming; IRON; GROWTH; TRANSPORTER; INHIBITION; CARCINOMA; GLUTAMINE; POTENT; LIVER;
D O I
10.16476/j.pibb.2023.0303
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There are huge differences between tumor cells and normal cells in material metabolism, and tumor cells mainly show increased anabolism, decreased catabolism, and imbalance in substance metabolism. These differences provide the necessary material basis for the growth and reproduction of tumor cells, and also provide important targets for the treatment of tumors. Ferroptosis is an iron-dependent form of cell death characterized by an imbalance of iron-dependent lipid peroxidation and lipid membrane antioxidant systems in cells, resulting in excessive accumulation of lipid peroxide, causing damage to lipid membrane structure and loss of function, and ultimately cell death. The regulation of ferroptosis involves a variety of metabolic pathways, including glucose metabolism, lipid metabolism, amino acid metabolism, nucleotide metabolism and iron metabolism. In order for tumor cells to grow rapidly, their metabolic needs are more vigorous than those of normal cells. Tumor cells are metabolically reprogrammed to meet their rapidly proliferating material and energy needs. Metabolic reprogramming is mainly manifested in glycolysis and enhancement of pentose phosphate pathway, enhanced glutamine metabolism, increased nucleic acid synthesis, and iron metabolism tends to retain more intracellular iron. Metabolic reprogramming is accompanied by the production of reactive oxygen species and the activation of the antioxidant system. The state of high oxidative stress makes tumor cells more susceptible to redox imbalances, causing intracellular lipid peroxidation, which ultimately leads to ferroptosis. Therefore, in-depth study of the molecular mechanism and metabolic basis of ferroptosis is conducive to the development of new therapies to induce ferroptosis in cancer treatment. Ferroptosis, as a regulated form of cell death, can induce ferroptosis in tumor cells by pharmacologically or genetically targeting the metabolism of substances in tumor cells, which has great potential value in tumor treatment. This article summarizes the effects of cellular metabolism on ferroptosis in order to find new targets for tumor treatment and provide new ideas for clinical treatment.
引用
收藏
页码:1540 / 1550
页数:11
相关论文
共 84 条
  • [11] Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis
    Chen, Guo-Qing
    Benthani, Fahad A.
    Wu, Jiao
    Liang, Deguang
    Bian, Zhao-Xiang
    Jiang, Xuejun
    [J]. CELL DEATH AND DIFFERENTIATION, 2020, 27 (01): : 242 - 254
  • [12] AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP/SLC7A11 signaling pathway
    Chen, Jinsi
    Zhang, Jia
    Tian, Wei
    Ge, Chao
    Su, Yuting
    Li, Jinjun
    Tian, Hua
    [J]. MOLECULAR CARCINOGENESIS, 2023, 62 (06) : 833 - 844
  • [13] Regulation and functional role of the electron transport chain supercomplexes
    Cogliati, Sara
    Luis Cabrera-Alarcon, Jose
    Antonio Enriquez, Jose
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2021, 49 (06) : 2655 - 2668
  • [14] The chemical basis of ferroptosis
    Conrad, Marcus
    Pratt, Derek A.
    [J]. NATURE CHEMICAL BIOLOGY, 2019, 15 (12) : 1137 - 1147
  • [15] The Role of AMP-activated Protein Kinase in Oxytosis/Ferroptosis: Protector or Potentiator?
    Currais, Antonio
    Kepchia, Devin
    Liang, Zhibin
    Maher, Pamela
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2022,
  • [16] Erastin-Like Anti-Warburg Agents Prevent Mitochondrial Depolarization Induced by Free Tubulin and Decrease Lactate Formation in Cancer Cells
    DeHart, David N.
    Lemasters, John J.
    Maldonado, Eduardo N.
    [J]. SLAS DISCOVERY, 2018, 23 (01) : 23 - 33
  • [17] The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer
    Delgir, Soheila
    Bastami, Milad
    Ilkhani, Khandan
    Sa, Asma
    Seif, Farhad
    Alivand, Mohammad Reza
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2021, 787
  • [18] Ferroportin Diseases: Functional Studies, a Link Between Genetic and Clinical Phenotype
    Detivaud, Lenaick
    Island, Marie-Laure
    Jouanolle, Anne-Marie
    Ropert, Martine
    Bardou-Jacquet, Edouard
    Le Lan, Caroline
    Mosser, Annick
    Leroyer, Patricia
    Deugnier, Yves
    David, Veronique
    Brissot, Pierre
    Loreal, Olivier
    [J]. HUMAN MUTATION, 2013, 34 (11) : 1529 - 1536
  • [19] Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
    Fan, Z.
    Wirth, A-K
    Chen, D.
    Wruck, C. J.
    Rauh, M.
    Buchfelder, M.
    Savaskan, N.
    [J]. ONCOGENESIS, 2017, 6 : e371 - e371
  • [20] Transferrin Receptor Is a Specific Ferroptosis Marker
    Feng, Huizhong
    Schorpp, Kenji
    Jin, Jenny
    Yozwiak, Carrie E.
    Hoffstrom, Benjamin G.
    Decker, Aubrianna M.
    Rajbhandari, Presha
    Stokes, Michael E.
    Bender, Hannah G.
    Csuka, Joleen M.
    Upadhyayula, Pavan S.
    Canoll, Peter
    Uchida, Koji
    Soni, Rajesh K.
    Hadian, Kamyar
    Stockwell, Brent R.
    [J]. CELL REPORTS, 2020, 30 (10): : 3411 - +